RxPros review
One advertised figure needs a year paid ahead, and the other is a first-month discount.
The verdict
RxPros advertises compounded semaglutide at $99.99 and tirzepatide at $144.97. Both rates require annual prepayment and ship every three months. The larger figures on the homepage are a first-month introductory discount for new patients.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- From
- From $99.99/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
RxPros sells both molecules by injection and lists branded products beside them. Medication arrives quarterly. The doctor visit and overnight shipping are stated as included in the price.
Who writes the prescription, and what do they see?
A doctor visit is inside the price rather than charged apart. RxPros does not say who conducts it or what it covers. Nothing describes a check between one quarterly shipment and the next.
The model is buy-ahead. A year is the term behind the advertised rate. Medication arrives three months at a time rather than monthly, so the cadence of care is quarterly by construction.
What happens when the dose goes up?
All doses are stated to cost the same, with no upcharge at a higher milligram. That is a real advantage. It also means a dose change arrives mid-consignment, and nothing published says how the remaining vials are handled.
What the price includes
Twelve months of semaglutide at $99.99 is $1,199.88 committed before a first injection. Tirzepatide at $144.97 is $1,739.64. Neither figure is offered month to month. The introductory rate applies to a first month only, and to new patients only.
What it claims, and what it cites
The two cheaper lines are compounded rather than manufactured. A pharmacy prepares them and is not named. The branded line is the manufacturer's product at a cash price.
Where it holds up, and where it does not
- Strength: Every dose at one price
- Strength: Doctor visit included in the rate
- Strength: Overnight delivery sits inside the price
- Strength: Branded options priced beside compounded
- Limitation: The advertised rate needs a year prepaid
- Limitation: Shipments arrive three months at a time
- Limitation: The second headline is a first-month rate
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about RxPros. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer prepared to pay a year ahead and take delivery quarterly.
- Wrong for
- A buyer who wants to stop after a month without money already spent.
The evidence behind what RxPros prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How RxPros compares
| Seller | Who it suits | Go |
|---|---|---|
 Rx.com | Buyers ready to pay six months at once for the figure in the headline | See Rx.com → |
 HeliMeds | Buyers converting a twelve-week plan into calendar months before comparing it | See HeliMeds → |
 NexLife | Buyers committing a full year rather than starting month to month | See NexLife → |
More GLP-1 telehealth sellers reviews: PreventiveMDPrideRxPrimary Clinic (Direct GLP)Prime Doctor RXPrime HealthQueen RX
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is $99.99 a monthly subscription?
- No. It is the annual-prepay rate, and the medication ships in three-month consignments.
- What does a year cost?
- $1,199.88 for semaglutide at the advertised rate, or $1,739.64 for tirzepatide.
- Does a higher dose cost more?
- No. RxPros states all doses carry the same price, and no dose surcharge is published.
- Is RxPros expensive compared with other GLP-1 telehealth sellers?
- RxPros publishes a starting figure of $99.99/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts RxPros below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.